Cargando…
Serum Chemokine CXCL7 as a Diagnostic Biomarker for Colorectal Cancer
Identification of effective biomarkers is crucial for monitoring the treatment and remission of colorectal cancer (CRC) and improving survival. It is particularly important to diagnose CRC before the tumor metastasizes (stage I–II disease) where possible, to provide the greatest opportunity for pati...
Autores principales: | Li, Longhai, Zhang, Lihua, Tian, Yu, Zhang, Ting, Duan, Guangliang, Liu, Yankui, Yin, Yuan, Hua, Dong, Qi, Xiaowei, Mao, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794610/ https://www.ncbi.nlm.nih.gov/pubmed/31649870 http://dx.doi.org/10.3389/fonc.2019.00921 |
Ejemplares similares
-
Serum Chemokine CXCL7 as a Potential Novel Biomarker for Obstructive Colorectal Cancer
por: Li, Longhai, et al.
Publicado: (2021) -
The Chemokine CXCL7 Is Related to Angiogenesis and Associated With Poor Prognosis in Colorectal Cancer Patients
por: Li, Longhai, et al.
Publicado: (2021) -
The synergized diagnostic value of VTQ with chemokine CXCL13 in lung tumors
por: Zhang, Xu, et al.
Publicado: (2023) -
Clinical and Prognostic Relevance of B7-H3 and Indicators of Glucose Metabolism in Colorectal Cancer
por: Zhang, Ting, et al.
Publicado: (2020) -
The regulatory network of the chemokine CCL5 in colorectal cancer
por: Zhang, Xin-Feng, et al.
Publicado: (2023)